Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%

MT Newswires Live

Mar 03

Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.

SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.

The company's Kiwi shares rose 5% in recent Tuesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2616536454"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616536454\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616536454?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 05:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616536454","market":"nz","top_or_hot":-1,"title":"Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-03 05:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK8033","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2616536454","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616536454","pubTimestamp":1772488209,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  signed a service agreement with Singapore General Hospital , enabling clinicians to order Cxbladder Triage, TriagePlus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use TriagePlus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK8033":"生物科技","PEB.NZ":"Pacific Edge Limited Ordinary Shares","PEB.AU":"PACIFIC EDGE LTD","BK7120":"特殊消费者服务","BK7067":"生物科技","BK7031":"贸易公司与经销商","SGH.AU":"SGH Ltd"},"translate_title":"Pacific Edge与新加坡总医院合作提供膀胱癌检测；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.NZ":1.5,"PEB.AU":1,"SGH.AU":1},"content_text":"Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}